Researchers are using nanotechnology to prevent the recurrence of solid tumors and destroy them.
Malignant cancers are a threat to the health of humans around the world, as people look forward to a longer life expectancy. Immunotherapy is being explored and developed to find new breakthroughs in the treatment of solid tumours.
To establish anti-tumor immune response, it is necessary to activate, expand and differentiate antigen-specific cells. This process is heavily dependent on the specific interactions between T cells and APCs in the body. Existing tumor vaccines such as neoantigens and vectors rely on random interaction with APCs. Inappropriate interactions can also silence other immune responses.
Immune checkpoint-based immune therapy has shown great potential. However, only a small percentage of patients respond fully to this treatment, and further research is needed to understand the molecular mechanisms involved. The delivery method used is complex and inefficient.
Source:
https://phys.org/news/2022-06-nanotechnology-relapse-solid-tumor-cancers.html
